Eli Lilly Commits USD 3 Billion To Expand China Manufacturing
Eli Lilly and Company plans to invest USD 3 billion in China over the next decade to expand its local manufacturing and supply chain capabilities as it prepares for potential demand for new diabetes and obesity treatments.
Eli Lilly Commits USD 3 Billion | 12/03/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy